Physician

Bruce Edward Silverstein, MD

According to 2025 Medicare claims, Bruce Silverstein, MD (NPI: 1255326476) practices ophthalmology in the Redding, CA market, with the plurality of this provider's patient population coming from Shasta, CA. This provider's primary affiliated billing organization is SHASTA EYE MEDICAL GROUP INC (NPI: 1346235603; TIN: 205756962) and primary practice location at 96001-0827.

Silverstein's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,039 traditional Medicare patients, billed 18,756 HCPCS/CPT codes, and received $2,704,276 in Medicare payments. The top billing code was 92014 (Established patient complete exam of visual system). Part D data shows 2,449 prescription claims across 780 beneficiaries totaling $171,002 in drug costs, led by Tobramycin-Dexamethasone (Tobramycin/Dexamethasone). 2023 DME data shows 13 claims. Open Payments data shows 16 records totaling $773. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $2,038,314 and ending at $2,704,276. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $307,382 and ending at $171,002. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,728	14,538	$2,038,314
2016	2,795	16,313	$2,618,154
2017	2,987	17,556	$3,007,544
2018	3,017	17,127	$2,542,538
2019	3,107	16,596	$1,989,164
2020	2,146	12,593	$1,510,594
2021	2,137	13,731	$1,908,573
2022	2,079	13,866	$1,776,281
2023	2,197	16,899	$2,134,622
2024	2,039	18,756	$2,704,276

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	805	2,985	$307,382
2016	797	2,625	$282,183
2017	884	2,778	$452,222
2018	819	2,637	$281,746
2019	565	1,656	$335,473
2020	674	2,094	$199,619
2021	698	2,213	$267,109
2022	734	2,135	$240,727
2023	722	2,148	$378,563
2024	780	2,449	$171,002

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	243	244	$15,852
2016	204	205	$11,858
2017	161	161	$10,504
2018	109	110	$7,246
2019	145	145	$8,543
2020	61	61	$3,821
2021	60	60	$4,018
2022	69	69	$4,781
2023	13	13	$797
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
92014	Established patient complete exam of visual system	1,275	1,587	$98
92012	Established patient problem focused exam of visual system	453	649	$69
92134	Imaging of retina	1,030	2,674	$34
92250	Photography of the retina	476	790	$30
92136	Measurement of corneal curvature and depth of eye	408	727	$20

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Tobramycin-Dexamethasone	Tobramycin/Dexamethasone	693	16,179	$28,604
Lumigan	Bimatoprost	39	2,673	$22,363
Miebo	Perfluorohexyloctane/Pf	21	690	$15,183
Restasis	Cyclosporine	11	690	$14,350
Prednisolone Acetate	Prednisolone Acetate	288	19,812	$11,022

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	16	$773	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Bruce Edward Silverstein, MD?

Tedicare shows public-source Medicare data for Bruce Edward Silverstein, MD (NPI 1255326476), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Bruce Edward Silverstein, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Bruce Edward Silverstein, MD?

Bruce Edward Silverstein, MD is linked to SHASTA EYE MEDICAL GROUP INC (billing NPI 1346235603) in the available physician profile data.

Does Bruce Edward Silverstein, MD have Open Payments data?

Bruce Edward Silverstein, MD has 16 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.